MoleMate—an innovative system that allows medical professionals to perform painless optical biopsies—has a number of favorable qualities. Cost-efficient and painless, it eliminates unnecessary biopsies and works as a decision support system for trained professionals.
One of the key favorable aspects of MoleMate system is its ability to provide clear and concise reports using the data collected during the SIAscans.
These reports are an excellent way to build patients’ confidence during and after the consultation because they are both immediate and informative. It is with this report that the medical professional can make referrals and decisions specific to each patient’s needs.
MoleMate comprises a hand-held scanner and SIAscopy: a skin imaging software that scans and visualizes hemoglobin, melanin, dermal melanin and collagen up to 2mm under the skin. SIAscopy provides medical professionals with a wealth of previously unavailable information and assists them in making instant clinical decisions about a lesion during the very first consultation.
Easy-to-Use, MoleMate acts as a support system, asking the medical professional questions about features in the images displayed on the screen. The scoring system aids in the detection of many types of suspicious lesions at the early stages before they are ever visible: ideal for early detection and prevention.
MoleMate also provides a magnified dermatoscopic view, which means that medical professionals used to dermoscopy will find the transition to MoleMate easy and familiar.
1. MoleMate has been clinically proven to increase the number of true positive referrals whilst potentially reducing practice costs and patient distress.
2. MoleMate is quick and simple to use.
3. MoleMate requires little training.
4. MoleMate incorporates patient details and notes with SIAscans into PDF reports.
5. MoleMate allows the clinician to scan and evaluate lesions within seconds.
6. MoleMate increases the number of true positive excisions/referrals to secondary care.
7. MoleMate rapidly assists in the identification of suspicious lesions.
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.
Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.
Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.
For more information about SIMSYS-MoleMate,
MedX Health Corp.
# # #
We customized marketing and promotional strategies that integrate Business Blogsites, Business Network Marketing, SEO, Email Marketing, Pay-Per-Click Marketing, ICross Media Sales Promotions, Branding and Integrated Marketing Communications.